rs729302 — IRF5

IRF5 rs729302 — The Interferon Dampener: A Protective Haplotype Tag

Interferon Regulatory Factor 5 (IRF5) is a master transcription factor for type I interferon production and proinflammatory cytokine secretion — a molecular switch that, when overactive, drives the chronic immune activation underlying systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, and Sjögren syndrome. rs729302 sits approximately 9 kilobases upstream of the IRF5 coding sequence in the 5' promoter region, where it serves as the key tag SNP¹¹ tag SNP
A variant in linkage disequilibrium with the true causal variant; used to track haplotypes when the causal site is unknown or difficult to genotype for a cluster of protective haplotypes that dampen interferon output. While rs10488631 (already documented separately) marks the 3' risk haplotype block that amplifies IRF5 activity, rs729302 marks an opposing 5' protective block — the other end of a molecular rheostat controlling how loudly your immune system broadcasts the interferon alarm.

The Mechanism

The rs729302 variant is an A-to-C substitution in the 5' regulatory region of IRF5. The common A allele is the reference (risk-direction) allele; the C allele is the minor allele that tags the protective haplotypes. In luciferase reporter gene assays using lymphoblastoid cells, the C allele showed borderline increased transcriptional activity and additional transcription factor binding relative to the A allele in electrophoretic mobility shift assays²² C allele showed borderline increased transcriptional activity and additional transcription factor binding relative to the A allele in electrophoretic mobility shift assays
Fernández-Hernández et al. 2013, Arthritis Research & Therapy; the functional difference was modest, suggesting rs729302 itself may not be causal but rather tags a nearby causal regulatory element.

The protective haplotypes tagged by rs729302-C reside in the 5' side of the IRF5 locus and are functionally distinct from — and independent of — the three-block risk haplotype system anchored by rs2004640, the exon 6 INDEL, and rs10488631. Conditional analysis in the landmark 14-cohort European SLE study demonstrated that the protective signal from rs729302 persisted after conditioning on all known susceptibility variants³³ persisted after conditioning on all known susceptibility variants
Including rs10488631, rs2004640, and the CGGGG promoter indel — indicating the protective signal is not simply an absence of risk alleles, establishing it as a genuinely independent protective locus within the gene. Subsequent work in the comprehensive HMG haplotype study found that the rs729302 association signal is partially explained by linkage disequilibrium with the CGGGG insertion-deletion polymorphism⁴⁴ linkage disequilibrium with the CGGGG insertion-deletion polymorphism
A 5-bp indel in the IRF5 promoter that creates or destroys an Sp1 transcription factor binding site, altering basal IRF5 transcription, but the variant remains the best available tag SNP for this protective haplotype block on current genotyping arrays.

The Evidence

The foundational evidence for rs729302 comes from the same landmark 14-cohort European study that identified rs10488631 as the leading IRF5 susceptibility signal. Examining 1,383 SLE cases and 1,614 controls, Ferreiro-Neira et al. found that two SNPs at the IRF5 locus showed independent and opposed associations⁵⁵ two SNPs at the IRF5 locus showed independent and opposed associations
Susceptibility: rs10488631, P<10⁻¹⁷; protection: rs729302, P<10⁻⁶. The protective signal from rs729302 was statistically independent of the susceptibility signal, meaning individuals can carry both — their net interferon tone reflecting a balance between the two haplotype blocks.

The protective direction is consistent across diseases and populations. In rheumatoid arthritis, a meta-analysis of five case-control studies (6,582 RA cases and 5,375 controls)⁶⁶ meta-analysis of five case-control studies (6,582 RA cases and 5,375 controls)
Han et al. 2009, Journal of Rheumatology confirmed the C allele is protective (random-effects OR=0.889, 95% CI 0.803–0.977, P=0.015). The same study found that allele frequencies differ meaningfully between cases and controls — the C allele is enriched in the healthy population relative to disease patients, a pattern seen across cohorts.

In Korean SLE patients, rs729302 showed the same directionality: the A allele was enriched in cases (frequency 0.729) compared to controls (frequency 0.680), yielding OR=1.27 (95% CI 1.08–1.49, P=0.0037)⁷⁷ OR=1.27 (95% CI 1.08–1.49, P=0.0037)
Shin et al. 2007, Arthritis Research & Therapy; Korean study mirroring European findings for the risk A allele. In Japanese RA patients, the A allele showed OR=1.22 (P<0.001) for disease susceptibility, with a particularly strong effect in HLA shared-epitope-negative patients (OR=1.50), suggesting rs729302 captures a distinct autoimmune pathway⁸⁸ suggesting rs729302 captures a distinct autoimmune pathway
One independent of the classical HLA shared epitope mechanism that dominates seropositive RA.

The C allele frequency in controls (approximately 32% in Europeans) versus cases (approximately 27%) in the Swedish SLE cohort represents a meaningful enrichment of the protective allele in the healthy population — quantitatively modest per allele, but clinically meaningful across a locus with such broad autoimmune relevance.

Practical Implications

Carrying one or two copies of the C allele at rs729302 indicates your IRF5 locus carries partial or full protective haplotype coverage in the 5' regulatory region. This does not confer immunity to autoimmune disease — environmental triggers, other genetic variants (including the 3' risk haplotype tagged by rs10488631), and stochastic immune events all play important roles. However, the C allele is measurably associated with lower interferon output and reduced disease susceptibility across multiple autoimmune conditions.

The most clinically relevant implication is in the context of the full IRF5 haplotype: individuals who carry the rs729302-C protective allele alongside the rs10488631-T (non-risk) allele have the lowest IRF5-mediated autoimmune risk, while those who carry rs729302-A alongside rs10488631-C face the highest. The intermediate scenarios — carrying protective alleles at one locus and risk alleles at the other — result in partially offsetting effects on interferon tone.

Interactions

rs729302 operates in the same IRF5 locus as rs2004640 (exon 1B splice site, documented separately) and rs10488631 (3' haplotype tag, documented separately). The three-block haplotype structure of IRF5 means individuals carry combinations of haplotypes across all three blocks simultaneously. The rs729302 protective haplotype is functionally and statistically independent of the rs10488631 susceptibility haplotype — they can coexist in the same genome, and the individual's net interferon phenotype reflects the sum of contributions across all three blocks.

The IRF5 locus also interacts additively with STAT4 (rs7574865), which encodes the signal transducer downstream of type I interferon. IRF5 drives interferon production; STAT4 amplifies cellular responsiveness to that interferon. rs729302-C carriers who also carry the STAT4 rs7574865 non-risk (CC) genotype have a double buffer — reduced production and reduced responsiveness — giving the most protected interferon pathway configuration.